Cumberland Vaprisol News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Cumberland Pharmaceuticals Reports First Quarter 2021 Financial Results & Company Update News provided by Share this article NASHVILLE, Tenn., May 11, 2021 /PRNewswire/   Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company, today is providing a company update and first quarter 2021 financial results. Net revenues from continuing operations during the quarter were $10.5 million, a 26.5% increase over the prior year period. The company also recorded an additional $500,000 in revenue during the first quarter associated with divested product rights for two brands it is no longer distributing. The Company s financial position included $93 million in total assets - with $25 million in cash, $46 million of total liabilities, and $47 million of shareholders equity at the end of the quarter.

United statesCumberland vibativCumberland vaprisolLife sciences centerHealth outcome predictive evaluationCumberland emerging technologies incCumberland pharmaceuticals incCumberland pharmaceuticalsVanderbilt universityChief executive officerCase studiesOral solutionDuchenne muscular dystrophySystemic sclerosisAspirin exacerbated respiratory diseaseCumberland emerging technologies